|
시장보고서
상품코드
2073746
핵산 치료제 CDMO 시장 : 유형별, 서비스별, 최종 용도별, 용도별, 국가별, 지역별 - 세계 산업 분석, 시장 규모, 점유율 및 예측(2026-2033년)Nucleic Acid Therapeutics CDMO Market, By Type, By Service, By End Use, By Application, By Country, and By Region -Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033 |
||||||
핵산 치료제 CDMO 시장 규모는 2025년에 175억 830만 달러로 평가되었고, 2026-2033년 CAGR 14.3%를 기록할 전망입니다.
핵산 의약품이란, 명확하게 정의된 서열을 가진 인공 올리고뉴클레오티드(DNA, RNA 또는 뉴클레오티드 염기의 유사체)의 한 유형로, 왓슨-크릭 염기쌍 형성을 통해 표적 DNA 서열과 결합할 수 있습니다. 핵산 의약품의 구조는 주사슬(포스포티오에이트 결합)이나 당 단위(2'-O-메틸 또는 락드 핵산)에 수정을 가할 수 있으며, 안티센스 결합, RNA 간섭 또는 스플라이싱 조절을 통해 표적 DNA의 유전자 발현을 제어할 수 있습니다. 따라서, 핵산 치료제는 고도의 표적 치료 전략을 위해 매우 특이적인 유전자 조절을 가능하게 합니다.
핵산 치료제 CDMO 시장 역학
RNA 기반 치료제의 급속한 확산이 시장 성장을 주도하고 있습니다.
RNA 기반 치료제의 부상은 이러한 RNA 기반 의약품의 개발 및 제조에 대한 수요가 증가함에 따라, 핵산 치료제 CDMO 시장의 발전에 영향을 미치는 주요 요인 중 하나가 되고 있습니다. 예를 들어, 미국 국립의학도서관(PMC)에 게재된 종합적인 리뷰에 따르면, 2026년에는 해당 리뷰에서 상세하게 설명된 바와 같이, mRNA, siRNA, ASO 및 RNA 편집 기술의 발전으로 인해 이미 전 세계적으로 20종 이상의 RNA 기반 의약품이 승인되었으며, 그 밖에도 암, 유전성 질환, 감염병, 대사성 질환의 치료를 목적으로 제1상, 제2상, 제3상 등 다양한 임상시험 단계에 있습니다. 이러한 임상 개발의 가속화로 인해 전 세계적으로 전문적인 CDMO 서비스에 대한 수요가 크게 증가하고 있습니다.
핵산 치료제 CDMO 시장 : 부문별 분석
세계 핵산 치료제 CDMO 시장은 유형, 서비스, 최종 용도, 용도 및 지역별로 분류됩니다.
용도별로는 RNA 및 DNA 기반 의약품 제조 분야의 발전으로 인해 바이러스성, 세균성 및 신종 감염병에 대한 핵산 의약품 수요가 증가하고 있어, 감염병 분야가 두드러진 점유율을 차지하고 있습니다. 2025년 5월, 다나하(Danaher) 산하의 알데브론(Aldevron)은 인티그레이티드 DNA 테크놀로지스(Integrated DNA Technologies)와 제휴하여, DNA 및 RNA의 첨단 제조 기술을 활용한 mRNA를 이용한 최초의 맞춤형 CRISPR 치료법을 도입했습니다. 이는 유전성 질환 및 감염증에 대한 차세대 핵산 의약품 개발에 기여하는 것입니다. 이러한 추세에 따라 전 세계적으로 핵산 치료제의 혁신과 보급이 더욱 가속화될 것으로 예측됩니다.
핵산 치료제 CDMO 시장 - 지역별 분석
북미는 우호적인 규제 환경, 투자 및 자금 조달의 활성화, 그리고 제품 승인 건수 증가에 힘입어 핵산 치료제 CDMO 시장을 주도했습니다. 예를 들어, 2026년에는 미국 과학·공학·의학 아카데미(National Academies of Sciences, Engineering, and Medicine)가 제안한 “치료법 혁신에 대한 투자를 질병 부담 및 미충족 의료 수요와 연계한다”라는 이니셔티브에 따라, 우선순위가 높은 건강 문제와 의료 서비스가 충분히 제공되지 않는 환자층을 대상으로 한 치료법에 대한 투자 확대에 점점 더 많은 관심이 쏠리고 있습니다. 본 조사에서는 헬스케어, 바이오의약품, 정책 각 분야의 전문가 16명으로 구성된 학제간 위원회를 결성하여, 미충족 수요가 가장 높은 분야에 대해 연구 개발 자금을 어떻게 하면 보다 효과적으로 배분할 수 있는지를 평가했습니다. 이러한 투자의 기세는 혁신을 가속화하고 지역 시장의 성장을 강화할 것으로 예측됩니다.
인도의 핵산 치료제 CDMO 시장 - 국가별 분석
인도의 핵산 치료제 CDMO 시장은 비용 대비 효율이 높은 제조 인프라, 우수한 인재, 그리고 WHO-cGMP를 준수하는 최첨단 제조 공장의 존재 덕분에 높은 성장이 예상됩니다. 예를 들어, CDSCO(인도 의약품 규제청)의 발표에 따르면, 현재까지 목록에 등재된 WHO-cGMP 인증을 취득한 의약품 제조 시설은 인도 국내 각 주에 2,006곳이 있으며, 이는 인도가 수많은 최고 수준의 WHO-cGMP 제조 시설을 보유하고 있음을 의미합니다. 구자라트주가 684곳의 WHO-cGMP 인증 제조 시설로 1위를 차지했으며, 그 뒤를 이어 마하라슈트라주가 229곳, 히마찰프라데시주가 202곳, 텔랑가나주가 172곳, 우타라칸드주가 128곳의 WHO-cGMP 제조 시설을 보유하고 있습니다. 이러한 견고한 제조거점을 바탕으로, 인도는 핵산 치료제 CDMO 서비스 분야에서 가장 선호되는 거점으로서의 입지를 확고히 하고 있습니다.
목차
제1장 핵산 치료제 CDMO 시장 개요
제2장 주요 요약
제3장 핵산 치료제 CDMO 주요 시장 동향
제4장 핵산 치료제 CDMO 시장 : 산업 분석
제5장 핵산 치료제 CDMO 시장 : 높아지는 지정학적 긴장의 영향
제6장 핵산 치료제 CDMO 시장 구도
제7장 핵산 치료제 CDMO 시장 : 유형별
제8장 핵산 치료제 CDMO 시장 : 서비스별
제9장 핵산 치료제 CDMO 시장 : 최종 용도별
제10장 핵산 치료제 CDMO 시장 : 용도별
제11장 핵산 치료제 CDMO 시장 : 지역별
제12장 주요 벤더 분석 : 핵산 치료제 CDMO 산업
제13장 AnalystView의 전방위적 분석
LSH 26.07.06Nucleic Acid Therapeutics CDMO market size was valued at US$ 17,508.3 Million in 2025, expanding at a CAGR of 14.3% from 2026 to 2033.
The nucleic acid drugs represent a family of artificial oligonucleotides (DNA, RNA, or analogs of nucleotide bases) with a well-defined sequence that will be able to bind with the target DNA sequence through Watson-Crick base pairing. The nucleic acid drug structure, which can undergo modifications to its backbone (phosphorothioate bonds) or sugar units (2'-O-methyl or locked nucleic acids), enables the manipulation of the gene expression of the target DNA by antisense binding, RNA interference, or splice modulation. Thus, nucleic acid therapeutics offer highly specific genetic regulation for advanced targeted treatment strategies.
Nucleic Acid Therapeutics CDMO Market- Market Dynamics
Rapid Expansion of RNA-Based Therapeutics to Drive Market Growth
The rise in RNA-based therapeutic drugs is among the main reasons that impact the development of the Nucleic Acid Therapeutics CDMO market owing to growing demands in the development and manufacturing of these RNA-based drugs. For instance, in 2026, according to a comprehensive review published in the U.S. National Library of Medicine (PMC), because of the advancements in mRNAs, siRNAs, ASOs, and RNA editing as described in detail in the review made by the U.S. National Library of Medicine (PMC). Already over 20 RNA-based drugs have been approved worldwide, while others are at different stages of clinical trials; that is, Phase I, II, and III, for treatments of cancer, genetic diseases, infectious diseases, and metabolic diseases. This accelerating clinical progress is significantly increasing demand for specialized CDMO capabilities worldwide.
Nucleic Acid Therapeutics CDMO Market- Segmentation Analysis:
The Global Nucleic Acid Therapeutics CDMO market is segmented on the basis of Type, Service, End Use, Application, and Region.
Among the given applications, infectious diseases account for a prominent share because of the growing need for nucleic acid drugs for viral, bacterial, and novel infections owing to the advances made in the field of RNA- and DNA-based drug manufacturing. In May 2025, Aldevron, which is a part of Danaher, partnered with Integrated DNA Technologies to introduce the first personalized CRISPR therapy using mRNA through advanced manufacturing technologies for DNA and RNA, contributing to the development of next generation nucleic acid medicines for genetic and infectious diseases. This trend is expected to further accelerate innovation and adoption of nucleic acid therapeutics globally.
Nucleic Acid Therapeutics CDMO Market- Geographical Insights
North America dominated the Nucleic Acid Therapeutics CDMO market due to its supportive regulatory environment, increasing investment and funding activities, and a rising number of product approvals. For instance, in 2026, according to the National Academies of Sciences, Engineering, and Medicine's initiative on aligning investments in therapeutic innovation with disease burden and unmet needs, growing attention is being directed toward increasing investment in therapeutics that address high-priority health challenges and underserved patient populations. The study brings together a multidisciplinary committee of 16 experts from healthcare, biopharmaceuticals, and policy to evaluate how research and development funding can be more effectively allocated toward areas with the greatest unmet medical need. This investment momentum is expected to accelerate innovation and strengthen regional market growth.
India Nucleic Acid Therapeutics CDMO market - Country Insights
The India Nucleic Acid Therapeutics CDMO market is expected to see high levels of growth owing to its cost-effective manufacturing infrastructure, high-caliber workforce, and the presence of high-end WHO-cGMP-compliant manufacturing plants. For instance, according to CDSCO Gov, there are 2,006 WHO-cGMP-certified pharmaceutical manufacturing facilities in India spread throughout different states in the list up till now, which means that India is blessed with many top-class WHO-cGMP manufacturing facilities. Gujarat stands first with 684 WHO-cGMP-certified manufacturing plants, followed by Maharashtra with 229, Himachal Pradesh with 202, Telangana with 172, and Uttarakhand with 128 WHO-cGMP manufacturing facilities. This strong manufacturing base positions India as a preferred hub for nucleic acid therapeutics CDMO services.
Nucleic Acid Therapeutics CDMO Market- Competitive Landscape:
Leading companies in the global market, including LGC Limited, Merck KGaA, WuXi AppTec, BIOSPRING, and Univercells Inc., are putting all their efforts into strategic growth. Such companies have been concentrating on collaborations, acquisitions, capacity expansion, and other service launches that could prove beneficial for their market shares, technologies, and worldwide presence. In October 2025, BIOSPRING launched manufacturing services for Luxna Biotech's unique XNA amidite portfolio that includes AmNA(TM), scpBNA(TM), and 5'-CP(TM) chemistries. The launch of this product line will improve the therapeutic oligonucleotide contract development and manufacturing organization services provided by BIOSPRING due to the advanced nucleic acid medicines with improved affinity, increased stability, and lower toxicity. These moves will increase the speed of innovations of companies operating in the global market.
Recent Developments:
In June 2026, Merck KGaA agreed to acquire Bio-Techne Corporation for approximately USD 11.3 billion, significantly expanding its life science business. The acquisition strengthens Merck's portfolio of research reagents, proteins, antibodies, and analytical tools supporting biopharmaceutical and nucleic acid therapeutics development.
In March 2026, Agilent Technologies launched Agilent Advanced Therapeutics, integrating its nucleic acid manufacturing and CDMO capabilities to provide end-to-end oligonucleotide development and production services supporting advanced therapeutic programs, including infectious disease-focused nucleic acid therapies.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL NUCLEIC ACID THERAPEUTICS CDMO MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Agilent Technologies, Inc.
- Curia Global, Inc.
- Ajinomoto Co., Inc.
- Danaher Corporation
- Aldevron
- Integrated DNA Technologies (IDT)
- KNC Laboratories Co., Ltd.
- LGC Limited
- Axolabs GmbH
- Merck KGaA
- WuXi AppTec Co., Ltd.
- BioSpring GmbH
- Univercells Inc.
- Exothera SA
- AGC Biologics, Inc.
- Asymchem Inc.
- Bachem AG
- BioCina
- CMIC HOLDINGS Co., Ltd.
- Eurofins Scientific SE
- Kaneka Corporation
- Others
GLOBAL NUCLEIC ACID THERAPEUTICS CDMO MARKET, BY TYPE- MARKET ANALYSIS, 2020 - 2033
- Plasmid DNA
- Antisense Oligonucleotides
- siRNA Therapeutics
- mRNA Therapeutics
- Gene Therapy
- Viral Vector-based Products
- Others
GLOBAL NUCLEIC ACID THERAPEUTICS CDMO MARKET, BY SERVICE- MARKET ANALYSIS, 2020 - 2033
- Process Development and Optimization
- Manufacturing Services
- Analytical and Quality Control Services
- Others
GLOBAL NUCLEIC ACID THERAPEUTICS CDMO MARKET, BY END USE- MARKET ANALYSIS, 2020 - 2033
- Pharmaceutical Companies
- Biotech Companies
- Government & Academic Research Institutes
- Others
GLOBAL NUCLEIC ACID THERAPEUTICS CDMO MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033
- Genetic Disorders
- Infectious Diseases
- Oncology
- Metabolic Disorders
- Rare Diseases
- Others
GLOBAL NUCLEIC ACID THERAPEUTICS CDMO MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Denmark
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Taiwan
- Vietnam
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Iran
- Qatar
- Rest of MEA
Table of Contents
1. Nucleic Acid Therapeutics CDMO Market Overview
- 1.1. Study Scope
- 1.2. Market Estimation Years
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. Nucleic Acid Therapeutics CDMO Market Snippet by Type
- 2.1.2. Nucleic Acid Therapeutics CDMO Market Snippet by Service
- 2.1.3. Nucleic Acid Therapeutics CDMO Market Snippet by End Use
- 2.1.4. Nucleic Acid Therapeutics CDMO Market Snippet by Application
- 2.1.5. Nucleic Acid Therapeutics CDMO Market Snippet by Country
- 2.1.6. Nucleic Acid Therapeutics CDMO Market Snippet by Region
- 2.2. Competitive Insights
3. Nucleic Acid Therapeutics CDMO Key Market Trends
- 3.1. Nucleic Acid Therapeutics CDMO Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Nucleic Acid Therapeutics CDMO Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Nucleic Acid Therapeutics CDMO Market Opportunities
- 3.4. Nucleic Acid Therapeutics CDMO Market Future Trends
4. Nucleic Acid Therapeutics CDMO Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. Nucleic Acid Therapeutics CDMO Market: Impact of Escalating Geopolitical Tensions
- 5.1. Impact of COVID-19 Pandemic
- 5.2. Impact of Russia-Ukraine War
- 5.3. Impact of Middle East Conflicts
6. Nucleic Acid Therapeutics CDMO Market Landscape
- 6.1. Nucleic Acid Therapeutics CDMO Market Share Analysis, 2025
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. Nucleic Acid Therapeutics CDMO Market - By Type
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Type, 2025 & 2033 (%)
- 7.1.2. Plasmid DNA
- 7.1.3. Antisense Oligonucleotides
- 7.1.4. siRNA Therapeutics
- 7.1.5. mRNA Therapeutics
- 7.1.6. Gene Therapy
- 7.1.7. Viral Vector-based Products
- 7.1.8. Others
8. Nucleic Acid Therapeutics CDMO Market - By Service
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Service, 2025 & 2033 (%)
- 8.1.2. Process Development and Optimization
- 8.1.3. Manufacturing Services
- 8.1.4. Analytical and Quality Control Services
- 8.1.5. Others
9. Nucleic Acid Therapeutics CDMO Market - By End Use
- 9.1. Overview
- 9.1.1. Segment Share Analysis, By End Use, 2025 & 2033 (%)
- 9.1.2. Pharmaceutical Companies
- 9.1.3. Biotech Companies
- 9.1.4. Government & Academic Research Institutes
- 9.1.5. Others
10. Nucleic Acid Therapeutics CDMO Market - By Application
- 10.1. Overview
- 10.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
- 10.1.2. Genetic Disorders
- 10.1.3. Infectious Diseases
- 10.1.4. Oncology
- 10.1.5. Metabolic Disorders
- 10.1.6. Rara Diseases
- 10.1.7. Others
11. Nucleic Acid Therapeutics CDMO Market - By Geography
- 11.1. Introduction
- 11.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
- 11.2. North America
- 11.2.1. Overview
- 11.2.2. Nucleic Acid Therapeutics CDMO Key Manufacturers in North America
- 11.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 11.2.4. North America Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 11.2.5. North America Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
- 11.2.6. North America Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 11.2.7. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.2.8. U.S.
- 11.2.8.1. Overview
- 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.2.8.3. U.S. Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 11.2.8.4. U.S. Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
- 11.2.8.5. U.S. Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 11.2.8.6. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.2.9. Canada
- 11.2.9.1. Overview
- 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.2.9.3. Canada Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 11.2.9.4. Canada Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
- 11.2.9.5. Canada Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 11.2.9.6. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3. Europe
- 11.3.1. Overview
- 11.3.2. Nucleic Acid Therapeutics CDMO Key Manufacturers in Europe
- 11.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 11.3.4. Europe Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 11.3.5. Europe Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
- 11.3.6. Europe Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 11.3.7. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.8. Germany
- 11.3.8.1. Overview
- 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.3.8.3. Germany Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 11.3.8.4. Germany Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
- 11.3.8.5. Germany Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 11.3.8.6. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.9. UK
- 11.3.9.1. Overview
- 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.3.9.3. UK Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 11.3.9.4. UK Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
- 11.3.9.5. UK Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 11.3.9.6. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.10. France
- 11.3.10.1. Overview
- 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.3.10.3. France Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 11.3.10.4. France Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
- 11.3.10.5. France Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 11.3.10.6. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.11. Italy
- 11.3.11.1. Overview
- 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.3.11.3. Italy Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 11.3.11.4. Italy Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
- 11.3.11.5. Italy Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 11.3.11.6. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.12. Spain
- 11.3.12.1. Overview
- 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.3.12.3. Spain Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 11.3.12.4. Spain Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
- 11.3.12.5. Spain Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 11.3.12.6. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.13. The Netherlands
- 11.3.13.1. Overview
- 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.3.13.3. The Netherlands Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 11.3.13.4. The Netherlands Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
- 11.3.13.5. The Netherlands Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 11.3.13.6. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.14. Sweden
- 11.3.14.1. Overview
- 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.3.14.3. Sweden Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 11.3.14.4. Sweden Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
- 11.3.14.5. Sweden Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 11.3.14.6. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.15. Russia
- 11.3.15.1. Overview
- 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.3.15.3. Russia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 11.3.15.4. Russia Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
- 11.3.15.5. Russia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 11.3.15.6. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.16. Poland
- 11.3.16.1. Overview
- 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.3.16.3. Poland Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 11.3.16.4. Poland Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
- 11.3.16.5. Poland Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 11.3.16.6. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.17. Denmark
- 11.3.17.1. Overview
- 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.3.17.3. Poland Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 11.3.17.4. Denmark Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
- 11.3.17.5. Denmark Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 11.3.17.6. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.18. Rest of Europe
- 11.3.18.1. Overview
- 11.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.3.18.3. Rest of the Europe Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 11.3.18.4. Rest of the Europe Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
- 11.3.18.5. Rest of the Europe Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 11.3.18.6. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4. Asia Pacific (APAC)
- 11.4.1. Overview
- 11.4.2. Nucleic Acid Therapeutics CDMO Key Manufacturers in Asia Pacific
- 11.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 11.4.4. APAC Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 11.4.5. APAC Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
- 11.4.6. APAC Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 11.4.7. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.8. China
- 11.4.8.1. Overview
- 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.4.8.3. China Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 11.4.8.4. China Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
- 11.4.8.5. China Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 11.4.8.6. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.9. India
- 11.4.9.1. Overview
- 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.4.9.3. India Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 11.4.9.4. India Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
- 11.4.9.5. India Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 11.4.9.6. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.10. Japan
- 11.4.10.1. Overview
- 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.4.10.3. Japan Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 11.4.10.4. Japan Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
- 11.4.10.5. Japan Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 11.4.10.6. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.11. South Korea
- 11.4.11.1. Overview
- 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.4.11.3. South Korea Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 11.4.11.4. South Korea Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
- 11.4.11.5. South Korea Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 11.4.11.6. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.12. Australia
- 11.4.12.1. Overview
- 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.4.12.3. Australia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 11.4.12.4. Australia Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
- 11.4.12.5. Australia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 11.4.12.6. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.13. Indonesia
- 11.4.13.1. Overview
- 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.4.13.3. Indonesia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 11.4.13.4. Indonesia Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
- 11.4.13.5. Indonesia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 11.4.13.6. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.14. Thailand
- 11.4.14.1. Overview
- 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.4.14.3. Thailand Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 11.4.14.4. Thailand Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
- 11.4.14.5. Thailand Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 11.4.14.6. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.15. Philippines
- 11.4.15.1. Overview
- 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.4.15.3. Philippines Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 11.4.15.4. Philippines Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
- 11.4.15.5. Philippines Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 11.4.15.6. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.16. Taiwan
- 11.4.16.1. Overview
- 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.4.16.3. Taiwan Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 11.4.16.4. Taiwan Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
- 11.4.16.5. Taiwan Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 11.4.16.6. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.17. Vietnam
- 11.4.17.1. Overview
- 11.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.4.17.3. Vietnam Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 11.4.17.4. Vietnam Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
- 11.4.17.5. Vietnam Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 11.4.17.6. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.18. Rest of APAC
- 11.4.18.1. Overview
- 11.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.4.18.3. Rest of APAC Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 11.4.18.4. Rest of APAC Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
- 11.4.18.5. Rest of APAC Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 11.4.18.6. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.5. Latin America (LATAM)
- 11.5.1. Overview
- 11.5.2. Nucleic Acid Therapeutics CDMO Key Manufacturers in Latin America
- 11.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 11.5.4. LATAM Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 11.5.5. LATAM Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
- 11.5.6. LATAM Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 11.5.7. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.5.8. Brazil
- 11.5.8.1. Overview
- 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.5.8.3. Brazil Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 11.5.8.4. Brazil Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
- 11.5.8.5. Brazil Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 11.5.8.6. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.5.9. Mexico
- 11.5.9.1. Overview
- 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.5.9.3. Mexico Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 11.5.9.4. Mexico Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
- 11.5.9.5. Mexico Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 11.5.9.6. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.5.10. Argentina
- 11.5.10.1. Overview
- 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.5.10.3. Argentina Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 11.5.10.4. Argentina Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
- 11.5.10.5. Argentina Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 11.5.10.6. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.5.11. Colombia
- 11.5.11.1. Overview
- 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.5.11.3. Colombia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 11.5.11.4. Colombia Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
- 11.5.11.5. Colombia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 11.5.11.6. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.5.12. Rest of LATAM
- 11.5.12.1. Overview
- 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.5.12.3. Rest of LATAM Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 11.5.12.4. Rest of LATAM Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
- 11.5.12.5. Rest of LATAM Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 11.5.12.6. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.6. Middle East and Africa (MEA)
- 11.6.1. Overview
- 11.6.2. Nucleic Acid Therapeutics CDMO Key Manufacturers in Middle East and Africa
- 11.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 11.6.4. MEA Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 11.6.5. MEA Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
- 11.6.6. MEA Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 11.6.7. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.6.8. Saudi Arabia
- 11.6.8.1. Overview
- 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.6.8.3. Saudi Arabia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 11.6.8.4. Saudi Arabia Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
- 11.6.8.5. Saudi Arabia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 11.6.8.6. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.6.9. United Arab Emirates
- 11.6.9.1. Overview
- 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.6.9.3. United Arab Emirates Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 11.6.9.4. United Arab Emirates Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
- 11.6.9.5. United Arab Emirates Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 11.6.9.6. United Arab Emirates Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.6.10. Israel
- 11.6.10.1. Overview
- 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.6.10.3. Israel Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 11.6.10.4. Israel Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
- 11.6.10.5. Israel Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 11.6.10.6. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.6.11. Turkey
- 11.6.11.1. Overview
- 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.6.11.3. Turkey Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 11.6.11.4. Turkey Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
- 11.6.11.5. Turkey Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 11.6.11.6. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.6.12. Algeria
- 11.6.12.1. Overview
- 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.6.12.3. Algeria Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 11.6.12.4. Algeria Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
- 11.6.12.5. Algeria Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 11.6.12.6. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.6.13. Egypt
- 11.6.13.1. Overview
- 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.6.13.3. Egypt Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 11.6.13.4. Egypt Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
- 11.6.13.5. Egypt Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 11.6.13.6. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.6.14. Iran
- 11.6.14.1. Overview
- 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.6.14.3. Iran Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 11.6.14.4. Iran Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
- 11.6.14.5. Iran Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 11.6.14.6. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.6.15. Qatar
- 11.6.15.1. Overview
- 11.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.6.15.3. Qatar Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 11.6.15.4. Qatar Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
- 11.6.15.5. Qatar Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 11.6.15.6. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.6.16. Rest of MEA
- 11.6.16.1. Overview
- 11.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.6.16.3. Rest of MEA Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 11.6.16.4. Rest of MEA Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
- 11.6.16.5. Rest of MEA Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 11.6.16.6. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12. Key Vendor Analysis- Nucleic Acid Therapeutics CDMO Industry
- 12.1. Competitive Benchmarking
- 12.1.1. Competitive Dashboard
- 12.1.2. Competitive Positioning
- 12.2. Company Profiles
- 12.2.1. Agilent Technologies, Inc.
- 12.2.2. Curia Global, Inc.
- 12.2.3. Ajinomoto Co., Inc.
- 12.2.4. Danaher Corporation
- 12.2.5. Aldevron
- 12.2.6. Integrated DNA Technologies (IDT)
- 12.2.7. KNC Laboratories Co., Ltd.
- 12.2.8. LGC Limited
- 12.2.9. Axolabs GmbH
- 12.2.10. Merck KGaA
- 12.2.11. WuXi AppTec Co., Ltd.
- 12.2.12. BioSpring GmbH
- 12.2.13. Univercells Inc.
- 12.2.14. Exothera SA
- 12.2.15. AGC Biologics, Inc.
- 12.2.16. Asymchem Inc.
- 12.2.17. Bachem AG
- 12.2.18. BioCina
- 12.2.19. CMIC HOLDINGS Co., Ltd.
- 12.2.20. Eurofins Scientific SE
- 12.2.21. Kaneka Corporation
- 12.2.22. Others
13. 360 Degree AnalystView
14. Appendix
- 14.1. Research Methodology
- 14.2. References
- 14.3. Abbreviations
- 14.4. Disclaimer
- 14.5. Contact Us
